Back to the main directory
EarningsReview / Equity
- Carlsberg (Buy, TP: DKK1110.00) - Asia (excluding China) miss by DnB Markets
- Nokian Tyres (Hold, TP: EUR7.50) - A not so merry winter season by DnB Markets
- Lundbeck (Buy, TP: DKK44.00) - Another increase to guidance likely by DnB Markets
- Sparebanken Øst (Hold, TP: NOK51.00) - Enhanced NII momentum by DnB Markets
- Skanska (Buy, TP: SEK205.00) - Impairments hit Q3; we still see value by DnB Markets
- NTG (Buy, TP: DKK365.00) - Still-compelling equity story by DnB Markets
- GN Group (Buy, TP: DKK215.00) - Adds company-compiled consensus by DnB Markets
- Elmera Group (Sell, TP: NOK15.00) - Watt’s up with margins by DnB Markets
- Ørsted (Buy, TP: DKK325.00) - Darker before the dawn by DnB Markets
- BUYs with much to look forward to by DnB Markets
- Itaú BBA on Apple: More Evidence That Fundamentals Will Deteriorate; We Remain Bearish by Itau
- Carlsberg A/S (CARLB DC) by HSBC
- HEYDUDE gets chomped by BNP Paribas Exane
- ISS - ISS could buy 1/4 of own shares in 2024-25 by Danske Bank Equity Research
- Continues to control, what they can control by BNP Paribas Exane
- Resource base materially expanding by BNP Paribas Exane
- All Metrics Improving Despite Macro; Among Best Value Props in Global Renewables by BNP Paribas Exane
- ISS - ISS could buy 1/4 of own shares in 2024-25 by Danske Bank Equity Research
- 3Q solid and clean; SHOP portfolio delivering robust growth by BNP Paribas Exane
- Services acceleration with iPhone outlook light by BNP Paribas Exane
- Fortum - Dividend risks increasing with declining power prices by Danske Bank Equity Research
- Solid 3Q with guidance raised; leverage down sharply on ATM by BNP Paribas Exane
- Axactor - Buy/NOK 8.50 (8.70): Still waiting for the sellers by Nordea
- Enefit Green - Buy/EUR 4.50 (5): Availability problems have continued by Nordea
- Kojamo plc - Buy/EUR 11: Plenty of time and options to solve 2025 maturities by Nordea
- AFRY (Sell, TP: SEK105.00) - Under pressure by DnB Markets
- A. P. Møller Mærsk (Sell, TP: DKK11500.00) - Set for another near-term beat by DnB Markets
- ALK-Abello (Buy, TP: DKK110.00) - All eyes on European tablet sales by DnB Markets
- SynAct Pharma (No_rec, TP: SEK) - Irregularities in the RESOLVE trial by DnB Markets
- Elektroimportøren (Buy, TP: NOK18.00) - EVolution by DnB Markets
- Multiconsult (Buy, TP: NOK155.00) - Low-season miss for the right reasons by DnB Markets
- Aker Biomarine (Buy, TP: NOK45.00) - Q3 beat and positive outlook by DnB Markets
- Wallenius Wilhelmsen ASA (Buy, TP: NOK140.00) - 2024e strength inbound by DnB Markets
- Valuation update by DnB Markets
- Americana Restaurants (AMR UH) by HSBC
- Itaú BBA on Credicorp: Not Bad Figures, but a Challenging Outlook by Itau
- Tata Motors (TTMT IN) by HSBC
- FQ1 24 results first take: OK quarter, but FY 24 guidance cut by BNP Paribas Exane
- Earnings call feedback: a lot to look forward to in 2024 by BNP Paribas Exane
- Weaker macro necessitates greater urgency on cost cuts by BNP Paribas Exane
- Long-term (Ken)view unch. but ST mixed catalysts by BNP Paribas Exane
- Another Warning Shot by BNP Paribas Exane
- Financial expenses weighing down deleverage by BNP Paribas Exane
- A prolonged IoT hangover? by BNP Paribas Exane
- Novo Nordisk - Warming up for FY 2024 by Danske Bank Equity Research
- Ambea - Buy/SEK 58 (52): Positive margin trajectory set to continue by Nordea
- BT Group Plc (BT/A LN) by HSBC
- Boreo - Commissioned research: Defending margins in a weaker market by Nordea
- Fortum - Buy/EUR 15: We forecast a stable dividend by Nordea
- Nordisk Bergteknik - Hold: Headwinds likely to linger in Q4 by Nordea